Suven Life Sciences granted patents in Canada, Europe & Hong Kong
Drug manufacturer Suven Life Sciences Ltd said it got three product patents from Canada, Europe & Hong Kong corresponding to new chemical entity for the treatment of disorders associated with Neurodegenerative diseases. The patents are valid through 2030-2032. According to the U.S. Food and Drug Administration, a new chemical entity (NCE) is a drug that […]